USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.80 | $-0.75 | $-0.59 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $840.00K | $761.00K | $658.00K |
Ayala Pharmaceuticals, Inc's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-0.74 | $-0.97 | $-0.59 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 6 | $-2.96 | $-3.50 | $-2.63 |
| Dec 2022 | 6 | $-2.77 | $-3.93 | $-0.69 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.74 | $-0.61 | $-0.61 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-2.96 | $-2.66 | $-2.57 |
| Dec 2022 | 0 / 0 | $-2.77 | $-2.33 | $-2.71 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $960.00K | $760.00K | $1.10M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $3.57M | $3.26M | $3.90M |
| Dec 2022 | 5 | $3.65M | $3.26M | $4.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $-0.80 | - | - |
| Aug 12, 2021 | Jun 2021 | $-0.62 | $-0.75 | -20.97% |
| May 14, 2021 | Mar 2021 | $-0.64 | $-0.74 | -16.54% |
| Mar 24, 2021 | Dec 2020 | $-0.58 | $-0.73 | -25.15% |
| Nov 16, 2020 | Sep 2020 | $-0.55 | $-0.59 | -8.18% |
| Aug 12, 2020 | Jun 2020 | $-0.51 | $-0.74 | -44.47% |
| Jun 22, 2020 | Mar 2020 | $-0.61 | $-1.32 | -117.46% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 24, 2021 | Dec 2020 | $-3.12 | $-3.38 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $840.00K | - | - |
| Aug 12, 2021 | Jun 2021 | $1.02M | $761.00K | 0.75% |
| May 14, 2021 | Mar 2021 | $1.30M | $974.00K | 0.75% |
| Mar 24, 2021 | Dec 2020 | $1.00M | $1.00M | 1.00% |
| Nov 16, 2020 | Sep 2020 | $0.00 | $658.00K | - |
| Aug 12, 2020 | Jun 2020 | $420.00K | $1.04M | 2.49% |
| Jun 22, 2020 | Mar 2020 | $280.00K | $1.00M | 3.58% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 24, 2021 | Dec 2020 | $3.71M | $3.71M | 0.00% |
AYLA's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 5 analysts, the average EPS estimation for Ayala Pharmaceuticals, Inc's next quarterly earnings is $-0.80, with a low EPS estimation of $-0.93, and a high estimation of $-0.70.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.80, the last 2 month trend is $-0.67, and the 3 month trend is $-0.63.
Based on 3 analysts, the average revenue estimation is $840.00K, with a low revenue estimation of $700.00K, and a high estimation of $1.00M.
Ayala Pharmaceuticals, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.
AYLA's earnings per share (EPS) was $-0.75, missing the consensus analysts forecast of $-0.62 by -20.97%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 1.35%, and lower than the same period a year before (Jun 2020) by 1.35%.
Revenues were $761.00K, worse than the forecast of $1.02M by -25.39%, down by -21.87% from the previous quarter , and down by -27.18% from the same period last year.
The company reported a net income of $-10.84M.Free cash flow for the quarter was $-11.55M , compared to $-9.65M last quarter and $-5.33M a year before.
AYLA ended the quarter with $502.00K in total debt, a decrease of -0.59% compared to the previous quarter, and a decrease of -8.39% compared to the same quarter a year before.
Ayala Pharmaceuticals, Inc's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.
AYLA's earnings per share (EPS) was $-3.38.
Revenues were $3.71M, better than the forecast of $3.71M by 0.00%, and up by 58.87% from previous year's revenue.
The company reported a net income of $-30.15M.
Ayala Pharmaceuticals, Inc reported a free cash flow of $-27.59M for its fiscal year, compared to $-16.28M a year ago.
The company ended the fiscal year with $553.00K in total debt, an increase of 84.95% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.